Jonas Schädlich

5PUBLICATIONS
22CO-AUTHORS
Biologically active moleculesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 12, 2026
An Approach Toward Radioiodination and Radiopharmacological Evaluation of a Carborane-Containing Analog of Indomethacin.

|Apr 01, 2026
Radioiodination of Two Carborane-Based Dual Cyclooxygenase-2/5-Lipoxygenase Inhibitors and Their In Vitro and In Vivo Evaluation.

Jonas Schädlich, Martin Ullrich, Cathleen Haase-Kohn

|Nov 13, 2025
Novel Ruthenacarborane-NSAID Conjugates.

Sonam Sonam, Marija Mojić, Vuk Gordić

|Oct 15, 2025
Investigation of the Putative Relationship Between Copper Transport and the Anticancer Activity of Cisplatin in Ductal Pancreatic Adenocarcinoma.

Alina Doctor, Jonas Schädlich, Sandra Hauser

|Mar 24, 2025
Carborane-Based Analogs of Celecoxib and Flurbiprofen, their COX Inhibition Potential, and COX Selectivity Index.

Lea Ueberham, Jonas Schädlich, Kim Schramke

Pageof 1

Frequent Collaborators

5 joint publications

Jens Pietzsch

4 joint publications

Markus Laube

4 joint publications

Evamarie Hey-Hawkins

2 joint publications

Klaus Kopka